Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism

被引：0
|
作者：
Reynolds, Miriam [1 ]
Clem, Brian [1 ]
机构：
[1] Univ Louisville, Dept Biochem, JGBrown Canc Ctr, Louisville, KY 40202 USA
来源：
CANCER & METABOLISM | 2014年 / 2卷
关键词：
D O I：
10.1186/2049-3002-2-S1-P61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Troglitazone suppresses tumor cell growth and glutamine metabolism through a PPAR-independent mechanism
    Miriam Reynolds
    Brian Clem
    Cancer & Metabolism, 2 (Suppl 1)
  • [2] Troglitazone suppresses glutamine metabolism through a PPAR-independent mechanism
    Reynolds, Miriam R.
    Clem, Brian F.
    BIOLOGICAL CHEMISTRY, 2015, 396 (08) : 937 - 947
  • [3] Bezafibrate induces a mitochondrial derangement in human cell lines: A PPAR-independent mechanism for a peroxisome proliferator
    Scatena, R
    Bottoni, P
    Vincenzoni, F
    Messana, I
    Martorana, GE
    Nocca, G
    De Sole, P
    Maggiano, N
    Castagnola, M
    Giardina, B
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (11) : 1440 - 1447
  • [4] Fenofibrate suppresses intestinal chloride secretion through a PPAR-independent inhibition of basolateral cAMP-activated K channels
    Bajwa, Poonam J.
    Lee, Jimmy W.
    Straus, Daniel S.
    Lytle, Christian
    FASEB JOURNAL, 2007, 21 (05): : A546 - A547
  • [5] Troglitazone suppresses cell growth of KU812 cells independently of PPAR-γ
    Abe, A
    Kiriyama, Y
    Hirano, M
    Miura, T
    Kamiya, H
    Harashima, H
    Tokumitsu, Y
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 436 (1-2) : 7 - 13
  • [6] Troglitazone inhibits expression of the PEPCK gene by a PPARγ-independent mechanism
    Roesler, WJ
    Khandelwal, RL
    Davies, GF
    DIABETES, 2000, 49 : A212 - A212
  • [7] Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPAR-independent pathway
    Tsubaki, Masanobu
    Takeda, Tomoya
    Tomonari, Yoshika
    Kawashima, Keishi
    Itoh, Tatsuki
    Imano, Motohiro
    Satou, Takao
    Nishida, Shozo
    JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (04) : 3638 - 3647
  • [8] Rosiglitazone suppresses human lung carcinoma cell growth through PPAR-γ-dependent and PPARγ-independent signal pathways
    Han, SW
    Roman, J
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (02) : 430 - 437
  • [9] Troglitazone, an anti-diabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of PPARγ
    Wang, MH
    Su, TZ
    FASEB JOURNAL, 1998, 12 (08): : A1456 - A1456
  • [10] Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism
    Akinyeke, Tunde O.
    Stewart, LaMonica V.
    CANCER BIOLOGY & THERAPY, 2011, 11 (12) : 1046 - 1058
12345